30 results
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
anticoagulant dosing ... DOAC #Bridging #Dosing ... Rivaroxaban #Edoxaban #Loading ... #DVT #Pharmacology ... #Hematology
Approach to the Rash in a an oncology patient - MINT-C Mnemonic
M - Malignancy: Leukemia cutis,
the Rash in a an oncology ... Gangrenosum, NEH T - Treatment ... dermatoses #skin ... #Rash #oncology ... MINTC #Mnemonic #dermatology
Cutaneous manifestations associated with myelodysplastic syndrome
 • Myeloid hemopathy with the most frequent skin lesions (20%)
most frequent skin ... synchronous or appearing during ... differential #diagnosis #dermatology ... #oncology #clinical ... #skin
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
interactions) Cancer-treatment ... DOACs thereby leading ... #Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
management #algorithm #pharmacology ... #treatment #medications ... decisionaid #cardiology #hematology ... #warfarin #dosing
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... for appropriate dosing ... Anticoagulation #Management #Hematology ... #Oncology
Behcet's Syndrome - Treatment
Ulcers:
 • Treatment: Topical steroids
 • Prevention: Colchicine
 • Azathioprine for refractory disease
Arthritis:
Ulcers: • Treatment ... Topical steroids • Prevention ... refractory disease Skin ... #management #pharmacology ... #rheumatology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... (A) Suggested treatment ... bleeding risk during ... Anticoagulation #Management #Hematology ... #Oncology
Topical Corticosteroid Potencies 
High Potency:
Betamethasone dipropionate 0.05% 
Clobestasol propionate 0.05%
Halobetasol propionate 0.05%
Desoximetasone 0.05%, 0.25%
Fluocinonide 0.05%
Medium Potency:
Betamethasone
the most common dermatologic ... For more severe skin ... If using high-potency ... Potency #Steroid #Pharmacology ... #Dermatology
Eosinophil Disorders Testing Algorithm
INDICATIONS FOR TESTING:
 • Peripheral blood eosinophilia/hypereosinophilia uncovered incidentally during medical evaluation or
uncovered incidentally during ... glucocorticoid treatment ... symptoms (eg, skin ... Differential #diagnosis #hematology